問卷

TPIDB > Principal Investigator

Principal Investigator


Taichung Veterans General Hospital (在職)

Division of Neurology

Taipei Veterans General Hospital (在職)

Division of Cardiovascular Surgery

CHANGHUA CHRISTIAN HOSPITAL (在職)

Division of Ophthalmology

更新時間:2024-06-07

陳柏霖CHEN, PO-LIN
  • Principal Investigator
  • Clinical Trial Experience (year)
  • boringtw@gmail.com

篩選

List

16Cases

2020-09-01 - 2024-10-09

Phase III

Completed
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion
  • Condition/Disease

    Macular Edema Secondary to Branch Retinal Vein Occlusion

  • Test Drug

    FARICIMAB (RO6867461)

Participate Sites
4Sites

Not yet recruiting4Sites

2020-09-01 - 2024-09-18

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2021-05-01 - 2024-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2022-04-01 - 2025-09-30

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Not yet recruiting2Sites

Recruiting5Sites

2020-07-15 - 2026-07-31

Phase IV

Active
A 12-month, Prospective, Multi-center Post-authorization Commitment (PAC) Study Monitoring Safety in Adult Patients With Relapsing-remitting Multiple Sclerosis Newly Initiated on Gilenya (Fingolimod) in Taiwan (SPRING)
  • Condition/Disease

    Multiple Sclerosis

  • Test Drug

    Gilenya hard Capsules 0.5mg

Participate Sites
6Sites

Not yet recruiting3Sites

Recruiting3Sites

2021-05-01 - 2024-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Not yet recruiting2Sites

Recruiting1Sites

2012-09-01 - 2016-09-01

Phase II

A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects with Brain Metastases from Non-Small Cell Lung Cancer
  • Condition/Disease

    Brain Metastases from Non-Small Cell Lung Cancer

  • Test Drug

    ABT-888 (Veliparib)

Participate Sites
6Sites

Terminated6Sites

2007-07-01 - 2012-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

1 2